Jonathan M. Raviotta

1.5k total citations
31 papers, 409 citations indexed

About

Jonathan M. Raviotta is a scholar working on Epidemiology, Health and Modeling and Simulation. According to data from OpenAlex, Jonathan M. Raviotta has authored 31 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Epidemiology, 16 papers in Health and 9 papers in Modeling and Simulation. Recurrent topics in Jonathan M. Raviotta's work include Influenza Virus Research Studies (23 papers), Vaccine Coverage and Hesitancy (15 papers) and Respiratory viral infections research (10 papers). Jonathan M. Raviotta is often cited by papers focused on Influenza Virus Research Studies (23 papers), Vaccine Coverage and Hesitancy (15 papers) and Respiratory viral infections research (10 papers). Jonathan M. Raviotta collaborates with scholars based in United States, South Korea and Canada. Jonathan M. Raviotta's co-authors include Richard K. Zimmerman, Mary Patricia Nowalk, Chyongchiou J. Lin, Kenneth J. Smith, Krissy Moehling Geffel, Jay V. DePasse, Eunha Shim, Shawn T. Brown, Hsin-Hui Huang and Song Zhang and has published in prestigious journals such as PEDIATRICS, American Journal of Epidemiology and Journal of the American Geriatrics Society.

In The Last Decade

Jonathan M. Raviotta

31 papers receiving 403 citations

Peers

Countries citing papers authored by Jonathan M. Raviotta

Since Specialization

Citations

This map shows the geographic impact of Jonathan M. Raviotta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan M. Raviotta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan M. Raviotta more than expected).

Fields of papers citing papers by Jonathan M. Raviotta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan M. Raviotta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan M. Raviotta. The network helps show where Jonathan M. Raviotta may publish in the future.

Co-authorship network of co-authors of Jonathan M. Raviotta

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan M. Raviotta. A scholar is included among the top collaborators of Jonathan M. Raviotta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan M. Raviotta. Jonathan M. Raviotta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cost-effectiveness of recombinant influenza vaccine compared with standard dose influenza vaccine in adults 18–64 years of age 2024 ·Vaccine ·Mary Patricia Nowalk, Kenneth J. Smith, Jonathan M. Raviotta, Angela R. Wateska, Richard K. Zimmerman	2
2	Influenza Vaccine Effectiveness Among Children: 2011–2020 2023 ·PEDIATRICS ·(unknown), Brendan Flannery, Manjusha Gaglani, Madhava Beeram, Karen J. Wernli, Michael L. Jackson, Emily T. Martin, Arnold S. Monto, Richard K. Zimmerman, Jonathan M. Raviotta, Edward A. Belongia, Huong Q. McLean, Sara Kim, Manish Patel, Jessie R. Chung	10
3	Vaccine effectiveness of recombinant and standard dose influenza vaccines against influenza related hospitalization using a retrospective test-negative design 2023 ·Vaccine ·Richard K. Zimmerman, Mary Patricia Nowalk, (unknown), Lloyd Clarke, Jonathan M. Raviotta, G.K. Balasubramani	10
4	Agent-based model of the impact of higher influenza vaccine efficacy on seasonal influenza burden 2022 ·Vaccine X ·Mary G. Krauland, Richard K. Zimmerman, Katherine V. Williams, Jonathan M. Raviotta, Lee H. Harrison, John V. Williams, Mark S. Roberts	6
5	Impact of Low Rates of Influenza on Next-Season Influenza Infections 2022 ·American Journal of Preventive Medicine ·Mary G. Krauland, David Galloway, Jonathan M. Raviotta, Richard K. Zimmerman, Mark S. Roberts	17
6	Estimating the Impact of Low Influenza Activity in 2020 on Population Immunity and Future Influenza Seasons in the United States 2021 ·Open Forum Infectious Diseases ·Kyueun Lee, Hawre Jalal, Jonathan M. Raviotta, Mary G. Krauland, Richard K. Zimmerman, Donald S. Burke, Mark S. Roberts	21
7	Agreement among sources of adult influenza vaccination in the age of immunization information systems 2021 ·Vaccine ·Mary Patricia Nowalk, (unknown), Richard K. Zimmerman, Sean Saul, Michael Susick, Jonathan M. Raviotta, Theresa M. Sax, G.K. Balasubramani	10
8	Compressed Influenza Vaccination in U.S. Older Adults: A Decision Analysis 2019 ·American Journal of Preventive Medicine ·Kenneth J. Smith, (unknown), Mary Patricia Nowalk, Jonathan M. Raviotta, Jay V. DePasse, Angela R. Wateska, Eunha Shim, Richard K. Zimmerman	3
9	Exploring the potential public health benefits of universal influenza vaccine 2019 ·Human Vaccines & Immunotherapeutics ·Jay V. DePasse, Mary Patricia Nowalk, Kenneth J. Smith, Jonathan M. Raviotta, Eunha Shim, Richard K. Zimmerman, Shawn T. Brown	2
10	Potential Cost-Effectiveness of a Universal Influenza Vaccine in Older Adults 2018 ·Innovation in Aging ·(unknown), Angela R. Wateska, Mary Patricia Nowalk, Jay V. DePasse, Jonathan M. Raviotta, Eunha Shim, Richard K. Zimmerman, Kenneth J. Smith	3
11	Cost-effectiveness and public health impact of alternative influenza vaccination strategies in high-risk adults 2017 ·Vaccine ·Jonathan M. Raviotta, Kenneth J. Smith, Jay V. DePasse, Shawn T. Brown, Eunha Shim, Mary Patricia Nowalk, Angela R. Wateska, (unknown), Richard K. Zimmerman	13
12	Using the 4 Pillars™ Practice Transformation Program to increase adolescent human papillomavirus, meningococcal, tetanus-diphtheria-pertussis and influenza vaccination 2017 ·Vaccine ·Richard K. Zimmerman, Jonathan M. Raviotta, Mary Patricia Nowalk, Krissy Moehling Geffel, Evelyn Cohen Reis, Sharon G. Humiston, Chyongchiou J. Lin	12
13	Cost-effectiveness of a statewide falls prevention program in Pennsylvania: Healthy Steps for Older Adults. 2016 ·PubMed ·Steven M. Albert, Jonathan M. Raviotta, Chyongchiou J. Lin, (unknown), Kenneth J. Smith	11
14	Using the 4 Pillars™ Practice Transformation Program to increase adult Tdap immunization in a randomized controlled cluster trial 2016 ·Vaccine ·Mary Patricia Nowalk, Chyongchiou J. Lin, Valory Pavlik, Anthony E. Brown, Song Zhang, Krissy Moehling Geffel, Jonathan M. Raviotta, Jeannette E. South-Paul, Mary Hawk, Edmund M. Ricci, Donald B. Middleton, Suchita A. Patel, Faruque Ahmed, Richard K. Zimmerman	12
15	Cost Effectiveness of Influenza Vaccine Choices in Children Aged 2–8 Years in the U.S. 2016 ·American Journal of Preventive Medicine ·Kenneth J. Smith, Jonathan M. Raviotta, Jay V. DePasse, Shawn T. Brown, Eunha Shim, Mary Patricia Nowalk, Richard K. Zimmerman	10
16	Cost Effectiveness of Influenza Vaccine for U.S. Children 2016 ·American Journal of Preventive Medicine ·Eunha Shim, Shawn T. Brown, Jay V. DePasse, Mary Patricia Nowalk, Jonathan M. Raviotta, Kenneth J. Smith, Richard K. Zimmerman	12
17	Improving adolescent HPV vaccination in a randomized controlled cluster trial using the 4 Pillars™ practice Transformation Program 2016 ·Vaccine ·Richard K. Zimmerman, Krissy Moehling Geffel, Chyongchiou J. Lin, Song Zhang, Jonathan M. Raviotta, Evelyn Cohen Reis, Sharon G. Humiston, Mary Patricia Nowalk	27
18	Using the 4 pillars™ practice transformation program to increase adult influenza vaccination and reduce missed opportunities in a randomized cluster trial 2016 ·BMC Infectious Diseases ·Chyongchiou J. Lin, Mary Patricia Nowalk, Valory Pavlik, Anthony E. Brown, Song Zhang, Jonathan M. Raviotta, Krissy Moehling Geffel, Mary Hawk, Edmund M. Ricci, Donald B. Middleton, Suchita A. Patel, Jeannette E. South-Paul, Richard K. Zimmerman	27
19	Do vitamin D levels affect antibody titers produced in response to HPV vaccine? 2015 ·Human Vaccines & Immunotherapeutics ·Richard K. Zimmerman, Chyongchiou J. Lin, Jonathan M. Raviotta, Mary Patricia Nowalk	15
20	Viral infections in outpatients with medically attended acute respiratory illness during the 2012–2013 influenza season 2015 ·BMC Infectious Diseases ·Richard K. Zimmerman, Charles R. Rinaldo, Mary Patricia Nowalk, G.K. Balasubramani, Krissy Moehling Geffel, Arlene Bullotta, Heather Eng, Jonathan M. Raviotta, Theresa M. Sax, Stephen R. Wisniewski	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact